492 AML-specific genes, including DOT1L, BCL2, and MEN1. KAT2A inhibition demonstrated anti-AML activity by inducing myeloid differentiation and apoptosis, suppressed the growth of AMLs. The gene discussed is DOT1L; the disease is acute myeloid leukemia.